# Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

> **NCT06965881** · PHASE1 · TERMINATED · sponsor: **GRIN Therapeutics, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Tuberous Sclerosis Complex (TSC)
- Focal Cortical Dysplasia
- Other Neurological Disorders

## Interventions

- **DRUG:** Radiprodil with Carbamazepine
- **DRUG:** Radiprodil with Itraconazole

## Key facts

- **NCT ID:** NCT06965881
- **Lead sponsor:** GRIN Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-05-08
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Study was terminated due to the lack of operational capabilities of the sites to segregate participants as needed.
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965881, "Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT06965881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*